ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $305,000 | -31.2% | 45,560 | +188.2% | 0.01% | -73.2% |
| Q1 2021 | $443,000 | -46.4% | 15,807 | -1.8% | 0.04% | -28.1% |
| Q2 2020 | $826,000 | -13.7% | 16,092 | -21.8% | 0.06% | -33.7% |
| Q2 2019 | $957,000 | +65.6% | 20,569 | +42.8% | 0.09% | +109.8% |
| Q1 2019 | $578,000 | +63.7% | 14,403 | +87.5% | 0.04% | +86.4% |
| Q4 2018 | $353,000 | -58.4% | 7,681 | -59.8% | 0.02% | -65.6% |
| Q3 2018 | $848,000 | +1.9% | 19,119 | +15.2% | 0.06% | -69.5% |
| Q3 2017 | $832,000 | +170.1% | 16,591 | -25.5% | 0.21% | +204.3% |
| Q3 2016 | $308,000 | -72.8% | 22,272 | -56.2% | 0.07% | -31.0% |
| Q4 2015 | $1,131,000 | -5.8% | 50,800 | -0.2% | 0.10% | -2.9% |
| Q3 2015 | $1,200,000 | – | 50,900 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |